News and Trends 11 Jan 2016
How about the $100M Holy ‘GRAIL’ in Cancer Diagnostics? A Universal Test Start-up Faces German Competition
…the circulating free tumor DNA (ctDNA) of cancer patients. New Oncology has also been investigating novel gene biomarkers in rarer cancers, such as infant Neuroblastoma, which they published in Nature…